Vaughan & Co Securities’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $716K | Sell |
18,639
-69
| -0.4% | -$2.65K | 0.41% | 29 |
|
|
2025
Q1 | $725K | Buy |
18,708
+4,805
| +35% | +$186K | 0.45% | 28 |
|
|
2024
Q4 | $470K | Sell |
13,903
-59
| -0.4% | -$2K | 0.28% | 47 |
|
|
2024
Q3 | $571K | Sell |
13,962
-55
| -0.4% | -$2.25K | 0.34% | 43 |
|
|
2024
Q2 | $540K | Sell |
14,017
-616
| -4% | -$23.7K | 0.34% | 44 |
|
|
2024
Q1 | $627K | Sell |
14,633
-1,827
| -11% | -$78.3K | 0.4% | 35 |
|
|
2023
Q4 | $610K | Sell |
16,460
-529
| -3% | -$19.6K | 0.41% | 40 |
|
|
2023
Q3 | $616K | Sell |
16,989
-207
| -1% | -$7.5K | 0.46% | 28 |
|
|
2023
Q2 | $613K | Sell |
17,196
-90
| -0.5% | -$3.21K | 0.44% | 36 |
|
|
2023
Q1 | $615K | Sell |
17,286
-6,773
| -28% | -$241K | 0.46% | 38 |
|
|
2022
Q4 | $845K | Buy |
+24,059
| New | +$845K | 0.67% | 20 |
|
|
2022
Q3 | – | Sell |
-13,334
| Closed | -$726K | – | 52 |
|
|
2022
Q2 | $726K | Sell |
13,334
-160
| -1% | -$8.71K | 0.58% | 27 |
|
|
2022
Q1 | $735K | Sell |
13,494
-104
| -0.8% | -$5.67K | 0.51% | 30 |
|
|
2021
Q4 | $750K | Buy |
13,598
+415
| +3% | +$22.9K | 0.51% | 25 |
|
|
2021
Q3 | $630K | Hold |
13,183
| – | – | 0.47% | 31 |
|
|
2021
Q2 | $656K | Hold |
13,183
| – | – | 0.48% | 29 |
|
|
2021
Q1 | $588K | Buy |
13,183
+4,197
| +47% | +$187K | 0.47% | 33 |
|
|
2020
Q4 | $414K | Sell |
8,986
-250
| -3% | -$11.5K | 0.37% | 37 |
|
|
2020
Q3 | $435K | Hold |
9,236
| – | – | 0.45% | 29 |
|
|
2020
Q2 | $471K | Sell |
9,236
-913
| -9% | -$46.6K | 0.52% | 27 |
|
|
2020
Q1 | $481K | Sell |
10,149
-26
| -0.3% | -$1.23K | 0.61% | 20 |
|
|
2019
Q4 | $598K | Buy |
+10,175
| New | +$598K | 0.54% | 29 |
|